← Open Payments lookup

CAROLYN SMALLWOOD: Open Payments

NPI 1578004552 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,293 in 106 payments from 21 companies in 2025. Trend: 2023 $2,072 · 2024 $3,146 · 2025 $2,293

Food & beverage: $2,293
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.16$398
Novartis Pharmaceuticals Corporation11$220
TG Therapeutics, Inc.8$187
UCB, Inc.6$184
Mallinckrodt Hospital Products Inc.8$160
Genentech USA, Inc.7$153
Biogen, Inc.10$148
Eisai Inc.5$126
Amgen Inc.5$116
ABBVIE INC.6$94

Products named: INGREZZA, KESIMPTA, BRIUMVI, Rystiggo, ACTHAR, TYSABRI, Ocrevus, Leqembi.

Industry payments across AL — which companies pay providers there.